YOLFTbeta
NeoGenomics Inc

NeoGenomics Inc

NEO · NASDAQ · Healthcare / Diagnostics & Research

16.02USD-0.52 (-3.14%)

Price History

Full chart

Market Stats

Previous Close16.54
Open16.50
Day Range15.67 – 16.50
52-Week Range7.07 – 20.05
Volume2.22M
Market Cap2.48B
P/E (TTM)0.00
Forward P/E222.22
EPS-0.39
Dividend Yield0.00%
Beta1.75
50-Day Avg16.78
200-Day Avg12.16

About

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Anthony P. Zook
  • Employees2.50K
  • Headquarters9490 NeoGenomics Way, Fort Myers, FL, United States, 33912, USA
  • Websitehttps://www.neogenomics.com

Leadership

  • Mr. Anthony P. ZookCEO & Director · b. 1961
  • Mr. Warren StonePresident & COO · b. 1973
  • Ms. Elizabeth A. FloegelChief Digital & Information Officer · b. 1976
  • Mr. Abhishek JainExecutive VP & CFO · b. 1976
  • Mr. Gregory D. AunanSenior VP & Chief Accounting Officer · b. 1969
  • Mr. Andrew Frederick Brackmann C.F.A.Vice President of Investor Relations
  • Mr. Clarence Cooper Esq.Vice President of Compliance & Privacy
  • Dr. Andrew A. Lukowiak Ph.D.Chief Innovation Officer · b. 1972
  • Priya VedaramanSenior Vice President of Finance
  • Ms. Kristi McKeownChief Commercial Officer

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue252.40K1.00K93.49K369.97K558.07K1.89M6.48M11.51M20.02M29.47M34.37M43.48M59.87M66.47M87.07M99.80M244.08M240.25M276.74M408.83M444.45M484.33M509.73M591.64M660.57M727.33M
Growth (%)--99.60%+9249.10%+295.73%+50.84%+237.77%+243.55%+77.66%+73.97%+47.23%+16.63%+26.51%+37.68%+11.02%+31.00%+14.62%+144.57%-1.57%+15.19%+47.73%+8.71%+8.97%+5.24%+16.07%+11.65%+10.11%
Cost of Revenue74.29K-189.96K481.59K576.87K1.19M2.76M5.52M9.35M14.25M18.59M24.06M33.03M34.73M46.35M56.05M133.70M138.29M149.48M211.99M258.56M297.27M321.83M347.04M370.47M444.79M
Gross Profit178.11K1.00K-96.47K-112.00K-18.79K696.92K3.72M5.98M10.66M15.21M15.78M19.43M26.84M31.74M40.71M43.76M110.38M101.96M127.27M196.84M185.89M187.06M187.90M244.60M290.10M282.54M
Gross Margin70.57%100.00%-103.18%-30.27%-3.37%36.97%57.40%51.99%53.27%51.63%45.92%44.68%44.83%47.75%46.76%43.84%45.22%42.44%45.99%48.15%41.83%38.62%36.86%41.34%43.92%38.85%
Operating Expense1.15M8.08M487.21K382.00K711.21K1.50M3.58M9.12M11.54M16.94M18.75M19.84M25.63M28.56M38.50M49.39M107.81M99.05M117.22M183.83M199.88M305.81M345.52M352.34M382.21M348.62M
Operating Income-971.00K-8.08M-583.67K-494.00K-730.00K-800.00K139.99K-3.14M-884.00K-1.73M-2.96M-409.00K1.21M3.17M2.22M-5.63M2.57M2.90M10.04M13.01M-13.99M-118.75M-157.62M-107.74M-92.11M-66.08M
Operating Margin-384.70%-807800.00%-624.31%-133.52%-130.81%-42.44%2.16%-27.30%-4.42%-5.86%-8.62%-0.94%2.02%4.78%2.55%-5.65%1.05%1.21%3.63%3.18%-3.15%-24.52%-30.92%-18.21%-13.94%-9.09%
EBITDA-945.00K-7.83M-790.98K-446.00K-625.00K-619.00K446.58K-2.63M-143.00K-544.00K-1.18M1.68M5.03M7.59M7.86M3.51M25.36M26.55M31.79M37.63M34.85M46.50M-82.33M-17.61M-1.51M-38.69M
EBITDA Margin-374.40%-783200.00%-846.05%-120.55%-111.99%-32.84%6.90%-22.90%-0.71%-1.85%-3.44%3.85%8.40%11.41%9.03%3.51%10.39%11.05%11.49%9.20%7.84%9.60%-16.15%-2.98%-0.23%-5.32%
Net Income-970.00K-8.08M-590.52K-536.00K-819.00K-997.00K-130.00K-3.38M-1.38M-2.24M-3.30M-1.18M65.00K2.03M1.13M-2.54M-6.14M-396.00K2.64M8.01M4.17M-8.35M-144.25M-87.97M-78.73M-108.03M
Net Income Margin-384.31%-807800.00%-631.64%-144.88%-146.75%-52.89%-2.01%-29.38%-6.91%-7.61%-9.61%-2.71%0.11%3.06%1.30%-2.54%-2.52%-0.16%0.95%1.96%0.94%-1.72%-28.30%-14.87%-11.92%-14.85%
R&D--46.41K--------543.00K2.28M2.44M2.69M4.20M4.65M3.64M3.00M8.49M8.23M21.87M30.33M27.31M31.16M37.08M
R&D as % of Total Revenue--49.65%--------1.25%3.81%3.67%3.09%4.21%1.90%1.51%1.08%2.08%1.85%4.52%5.95%4.62%4.72%5.10%
Interest Expense6460207.31K41.43K0196.80K325.63K24.26K308.52K532.39K710.00K768.00K1.15M989.00K929.00K854.00K10.00M5.54M6.23M3.71M7.02M8.22M7.58M6.91M6.62M3.75M
Interest Expense % of Total Revenue0.26%0.00%221.74%11.20%0.00%10.44%5.03%0.21%1.54%1.81%2.07%1.77%1.91%1.49%1.07%0.86%4.10%2.31%2.25%0.91%1.58%1.70%1.49%1.17%1.00%0.52%

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets18681.34K447.84K507.04K592.00K1.08M3.13M6.52M7.30M12.95M13.65M19.95M30.07M39.92M81.11M367.95M337.12M343.34M505.01M709.51M988.33M1.87B1.74B1.68B1.64B1.36B
Total Liabilities125.03K186.22K424.49K874.84K1.02M2.08M3.08M4.20M5.79M7.30M10.52M14.05M20.86M18.20M20.70M129.84M150.52M137.81M184.57M202.10M294.04M761.50M742.01M739.69M735.70M523.27M
Total Equity-124.84K-104.87K23.34K-367.80K-426.65K-994.94K54.51K2.32M1.50M5.64M3.13M5.90M9.22M21.71M60.41M238.11M186.60M205.53M320.44M507.41M694.29M1.11B998.02M941.54M902.34M836.56M
Cash18677.22K-25.05K112.55K10.94K126.27K210.57K468.17K1.63M1.10M2.63M1.87M4.83M33.69M23.42M12.53M12.82M9.81M173.02M228.71M316.83M263.18M342.49M367.01M159.62M
Total Debt--13.52K590.00K--543.38K1.08M3.19M3.56M6.79M8.61M13.77M10.36M8.48M71.38M127.86M105.42M112.30M132.88M218.22M612.79M610.93M611.68M605.33M472.28M
Net Debt-186-77.22K13.52K564.95K-112.55K-10.94K417.11K869.47K2.72M1.93M5.69M5.99M11.90M5.53M-25.21M47.96M93.64M92.60M102.49M-40.14M-10.49M295.96M347.75M269.19M238.32M312.66M

Cash Flow

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-177.13K-77.41K-384.80K-532.37K-658.13K-902.05K-693.78K-2.64M-138.31K-1.50M-2.05M69.00K-492.00K2.23M9.45M6.39M21.48M18.04M44.79M23.37M1.46M-26.72M-65.99M-1.95M7.02M5.23M
Investing Cash Flow--2.69K-418.00K-63.19K-85.93K-117.63K-398.62K-716.14K-501.78K-963.74K-916.00K-897.00K-3.65M-2.01M-9.60M-75.16M-6.50M-13.69M-139.69M-19.63M-159.44M-632.37M517.00K76.71M12.86M-12.34M
Financing Cash Flow133.70K157.31K725.58K620.61K831.56K918.08K1.21M3.44M897.68K3.63M2.43M2.36M3.38M2.75M29.01M58.49M-25.87M-4.09M91.96M159.47M235.60M725.28M11.83M4.55M4.65M-200.29M
Capital Expenditure02.90K418.00K63.19K85.93K117.63K398.62K516.14K501.78K963.74K916.00K897.00K3.65M2.01M3.77M2.21M7.54M13.69M14.31M20.03M29.10M64.14M30.89M28.75M41.06M27.01M
Free Cash Flow-177.13K-80.31K-802.79K-595.55K-744.07K-1.02M-1.09M-3.16M-640.09K-2.46M-2.97M-828.00K-4.14M216.00K5.68M4.18M13.94M4.35M30.48M3.34M-27.64M-90.86M-96.88M-30.70M-34.04M-21.78M
Dividends Paid-----------0000087.86M09.60M-------
FCF to OCF100.00%103.75%208.63%111.87%113.06%113.04%157.46%119.53%462.80%164.23%144.64%-1200.00%842.28%9.70%60.08%65.35%64.91%24.10%68.05%14.29%-1892.88%340.03%146.81%1572.20%-484.66%-416.41%
Dividend Paid to FCF-----------0.00%0.00%0.00%0.00%0.00%630.20%0.00%31.50%-------

Earnings

Report DateMar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Feb 28, 2007May 9, 2007Aug 2, 2007Nov 14, 2007Mar 18, 2008May 7, 2008Jul 31, 2008Nov 6, 2008Mar 5, 2009Apr 23, 2009Jul 28, 2009Oct 29, 2009Feb 25, 2010Apr 29, 2010Jul 29, 2010Oct 28, 2010Feb 10, 2011Apr 21, 2011Jul 20, 2011Oct 19, 2011Feb 16, 2012Apr 25, 2012Jul 19, 2012Oct 31, 2012Feb 14, 2013Apr 25, 2013Jul 31, 2013Oct 23, 2013Feb 19, 2014Apr 23, 2014Jul 17, 2014Oct 30, 2014Feb 24, 2015Apr 28, 2015Jul 23, 2015Oct 29, 2015Mar 1, 2016Apr 27, 2016Jul 26, 2016Oct 26, 2016Feb 22, 2017Apr 26, 2017Jul 25, 2017Oct 25, 2017Feb 21, 2018May 1, 2018Jul 24, 2018Oct 30, 2018Feb 19, 2019Apr 30, 2019Jul 30, 2019Oct 29, 2019Feb 27, 2020Apr 28, 2020Jul 28, 2020Oct 27, 2020Feb 24, 2021May 5, 2021Aug 6, 2021Nov 4, 2021Feb 23, 2022Apr 27, 2022Aug 9, 2022Nov 8, 2022Feb 23, 2023May 8, 2023Aug 8, 2023Nov 6, 2023Feb 20, 2024Apr 30, 2024Jul 29, 2024Nov 5, 2024Feb 18, 2025Apr 29, 2025Jul 29, 2025Oct 28, 2025Feb 17, 2026May 5, 2026Jul 28, 2026Oct 27, 2026
EPS Estimate--------------------------0.01-0.01-0.01-0.01-0.01-0.010.01-0.01-0.01-0.04-0.02-0.02-0.02-0.02-0.01-0.01-0.01-0.010.01-0.01-0.01--0.010.02-0.01-0.010.01-0.01-0.01-0.020.010.030.030.030.030.030.020.040.030.040.020.040.040.060.060.060.02-0.100.040.060.01-0.06-0.09-0.15-0.24-0.23-0.21-0.16-0.15-0.11-0.08-0.03-0.05-0.000.010.03-0.010.020.020.040.01-0.06-0.01
EPS Actual-0.23-0.30-0.48-0.35-0.20-0.24-0.14-0.18-0.17-0.03-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.020.000.010.00-0.02-0.01-0.03-0.02-0.05-0.010.00-0.01-0.010.000.00-0.02-0.04-0.02-0.03-0.03-0.01-0.02-0.01-0.000.000.010.01-0.02-0.000.000.010.020.020.000.010.010.02-0.01-0.00-0.00-0.030.030.040.040.050.030.040.010.050.040.050.050.060.070.070.070.10-0.02-0.040.060.14-0.04-0.01-0.08-0.14-0.20-0.16-0.14-0.06-0.09-0.05-0.020.03-0.020.03-0.140.04-0.200.030.030.060.01-0.01-
Surprise-------------------------0.00%-200.00%-100.00%-400.00%0.00%--200.00%-200.00%--98.00%-100.00%0.00%0.00%-50.00%-50.00%50.00%-100.00%0.00%67.00%-0.00%0.00%-100.00%77.00%--100.00%0.00%-0.00%200.00%100.00%0.00%71.00%--250.00%200.00%33.33%33.33%66.67%0.00%33.33%-50.00%25.00%33.33%25.00%150.00%50.00%75.00%16.67%16.67%66.67%-200.00%60.00%50.00%133.33%-500.00%83.33%11.11%6.67%16.67%30.43%33.33%62.50%40.00%54.55%75.00%200.00%60.00%1404.35%-1494.00%39.86%-1935.00%50.00%50.00%50.00%-12.28%83.33%-
Timing-----------------------------Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.48B
Enterprise Value2.66B
Trailing P/E0.00
Forward P/E222.22
PEG Ratio2.09
Price / Sales3.23
Price / Book3.00
EPS-0.39
Book Value6.14
Revenue (TTM)766.29M
Gross Profit (TTM)336.53M
EBITDA24.32M
Profit Margin-6.77%
Operating Margin-4.84%
Return on Equity-6.33%
Return on Assets-1.89%
Shares Outstanding128.48M
Shares Float117.02M
Beta1.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 12 analystsTarget 19.72
  • Strong Buy
    6
  • Buy
    2
  • Hold
    4

Ownership Breakdown

Institutions
115.24%
Insiders
2.11%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    19.96M15.53%
  • First Light Asset Management, LLC
    12.28M9.56%
  • First Trust Advisors L.P.
    10.11M7.87%
  • Greenhouse Funds LLLP
    8.57M6.67%
  • Vanguard Portfolio Management, LLC
    7.62M5.93%
  • Vanguard Capital Management, LLC
    5.66M4.40%
  • BRAIDWELL LP
    5.62M4.37%
  • State Street Corp
    5.12M3.99%
  • Schroder Investment Management Group
    4.34M3.38%
  • Delaware Management Holdings Inc
    3.45M2.69%
  • Geode Capital Management, LLC
    3.23M2.51%
  • Millennium Management LLC
    3.08M2.40%
  • Bank of America Corp
    3.05M2.38%
  • Loomis, Sayles & Company LP
    2.54M1.98%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    7.94M6.18%
  • First Trust NYSE Arca Biotech ETF
    6.42M4.99%
  • Vanguard MStar Total Stk Mkt Idx Invest
    4.15M3.23%
  • Nomura Small Cap Core I
    4.08M3.18%
  • iShares Russell 2000 ETF
    3.36M2.61%
  • Vanguard Small Cap Index
    2.99M2.33%

Dividends

20201×
0.40Dec 17, 2020

Stock Splits

  • Apr 16, 20031:100
  • Nov 17, 20004:1